INTERLEUKIN-1 ALPHA MODULATES MEGAKARYOCYTE MATURATION AND PLATELET PRODUCTION IN VITRO
EHA Library, Robert Kolman, 420255
ANTIRETROVIRAL DRUGS DISPLAY VARYING TOXIC AND STIMULATORY EFFECTS ON UMBILICAL CORD BLOOD DERIVED HAEMATOPOIETIC STEM/PROGENITOR CELLS IN VITRO
EHA Library, Candice Hendricks, 420256
PHYSICAL AND FUNCTIONAL INTERACTION AMONG IRF8 ENHANCERS DURING DENDRITIC CELL DIFFERENTIATION
EHA Library, Takaya Yamasaki, 420257
INTERACTIONS BETWEEN MESENCHYMAL STEM CELLS AND MACROPHAGES IN STRESS ERYTHROPOIESIS: ROLES FOR NITRIC OXIDE AND PURINERGIC SIGNALLING
EHA Library, Sanja Momčilović, 420258
ZANUBRUTINIB ENHANCES CD19 CART KILLING OF B-CELL LYMPHOMA BY INHIBITING BTK PHOSPHORYLATION, REGULATING PI3K/AKT/MTOR PATHWAY AND PROMOTING AUTOPHAGY
EHA Library, Hao Yao, 420259
SUCCESSFUL CORRECTION OF G6PD VIANGCHAN MUTATION BY PRIME EDITING
EHA Library, Chaiwat Netsawang, 420260
AN EXPERIMENTAL STUDY OF CD4 TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELL WITH ANTILYMPHOMA ACTIVITY
EHA Library, Zong Zhai, 420261
FEASIBILITY OF ULTRA-LOW INPUT RNA SEQUENCING OF INVARIANT NKT CELLS IN PATIENTS WITH MULTIPLE MYELOMA
EHA Library, Robin Klieber, 420262
IMPROVING CAR T CELL CULTURE BY INHIBITION OF DE NOVO DNA METHYLATION
EHA Library, Alexander Seitz, 420263
REGULATORY T CELLS EXPRESSING CD19-TARGETED CHIMERIC ANTIGEN RECEPTOR RESTORE HOMEOSTASIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
EHA Library, Matteo Doglio, 420264
ROLE OF CARDIAC BIOMARKERS IN THE MANAGEMENT OF PATIENTS UNDERGOING CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: A SINGLE-CENTRE RETROSPECTIVE ANALYSIS FROM THE ROYAL MARSDEN HOSPITAL.
EHA Library, Katy Smith, 420265
RECONSTITUTION OF INVARIANT NATURAL KILLER T CELLS POST-ALLOGENEIC STEM CELL TRANSPLANTATION: PILOT DATA FOR A PHASE I CLINICAL TRIAL
EHA Library, Tomas Kriz, 420266
PROPHYLACTIC DEXAMETHASONE IS ASSOCIATED WITH LOWER GRADE 3-4 NEUROTOXICITY AFTER AXICABTAGENE CILOLEUCEL FOR NON-HODGKIN LYMPHOMA: RESULTS OF A SINGLE-INSTITUTION STUDY
EHA Library, Anthony Stack, 420267
DAPRODUSTAT IMPROVES ANEMIA IN A MOUSE MODEL OF SICKLE CELL DISEASE
EHA Library, Malini Sharma, 420268
DEVELOPMENT OF A TREATMENT DECISION-MAKING TOOL FOR SICKLE CELL DISEASE (SCD) MANAGEMENT: THE MANAGE, MONITOR, REALIZE (MMR) FRAMEWORK
EHA Library, Françoise Bernaudin, 420269
MITOCHONDRIAL RETENTION IN MATURE RED BLOOD CELLS FROM PATIENTS WITH SICKLE CELL DISEASE IS ASSOCIATED WITH STRESS ERYTHROPOIESIS BUT NOT WITH PROINFLAMMATORY STATE
EHA Library, Maryse Etienne-Julan, 420270
NON-INVASIVE PRENATAL DIAGNOSIS OF SICKLE CELL DISEASE. PILOT STUDY
EHA Library, Sara Ferrer, 420271
EVALUATING ERYTHROCYTE SUBPOPULATIONS IN SICKLE CELL DISEASE: LINKS TO HEMOLYSIS AND OXIDATIVE STRESS
EHA Library, Alkmini Anastasiadi, 420272
INTEGRATION OF POINT OF CARE TESTING IN PRIMARY HEALTH CARE FACILITIES FOR EARLY COMPREHENSIVE MANAGEMENT OF SICKLE CELL DISEASE IN RURAL KASSENA NANKANA DISTRICTS OF GHANA.
EHA Library, Lucy Osei Ababio, 420273
STUDY OF SAFETY AND EFFICACY OF THALIDOMIDE IN COMBINATION WITH HYDROXYUREA IN PATIENTS OF SICKLE CELL ANAEMIA: A RANDOMISED CLINICAL TRIAL FROM EASTERN INDIA
EHA Library, Anindita Paul, 420274
HEMMA - AN OBSERVATIONAL STUDY REVEALING DISTINCT NOVEL BIOMARKER PROFILES FOR SICKLE CELL DISEASE PATIENTS COMPARED TO ETHNICITY-MATCHED CONTROL SUBJECTS
EHA Library, Alicia Rovó, 420275
EVALUATION OF TRANSFUSION PRACTICE FOR SICKLE CELL DISEASE IN A BELGIAN REFERENCE CENTER
EHA Library, Yvan Momo, 420276
THE OUTCOME OF SICKLE CELL DISEASE PATIENTS POST-HEMATOPOIETIC STEM CELL TRANSPLANTATION: A RETROSPECTIVE STUDY IN RIYADH, SAUDI ARABIA
EHA Library, Abdulrahman Nasiri, 420277
CLINICAL COMPLICATIONS AND TREATMENT USE AMONG PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN THE NETHERLANDS
EHA Library, Nanxin Li, 420278
TRANSFUSION ASSOCIATED COSTS FOR SICKLE CELL DISEASE IN EUROPE: A SYSTEMATIC LITERATURE REVIEW
EHA Library, Giovanna Barcelos, 420279
STUDY DESIGN OF THE PHASE 3 PORTION OF RISE UP: A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MITAPIVAT IN PATIENTS WITH SICKLE CELL DISEASE
EHA Library, Biree Andemariam, 420280
THE LAUNCH OF A GLOBAL, PHASE 2, OPEN-LABEL, MULTICENTER, SINGLE-ARM STUDY OF MITAPIVAT IN PATIENTS WITH SICKLE CELL DISEASE AND NEPHROPATHY
EHA Library, Fuad El Rassi, 420281
OPTIMISATION OF THE DANISH NATIONAL HAEMOGLOBINOPATHY SCREENING PROGRAMME – A PROSPECTIVE INTERVENTION STUDY
EHA Library, Esther Gravholt, 420282
THE DIRECT COSTS OF TRANSFUSION-DEPENDENT BETA-THALASSEMIA IN SAUDI ARABIA: A COST OF ILLNESS ANALYSIS STUDY
EHA Library, Ahlam Alshehri, 420283
BORDERLINE HEMOGLOBIN A2 LEVELS AND DIAGNOSIS OF THE  -101 (C>T) MUTATION IN NORTHERN GREECE
EHA Library, Stamatia Theodoridou, 420285
SINGLE-CENTRE OUTCOMES OF ALEMTUZUMAB-TBI CONDITIONING IN ADULT TRANSFUSION-DEPENDENT Β-THALASSAEMIA PATIENTS UNDERGOING MATCHED SIBLING TRANSPLANTS
EHA Library, Thomas Erblich, 420286
MORTALITY FACTORS IN INDIVIDUALS WITH HEMOGLOBINOPATHIES: A TEN-YEAR REGISTRY FROM GREECE.
EHA Library, Sofia Delicou, 420287
CRYOGENIC SCANNING ELECTRON MICROSCOPY OF RED BLOOD CELLS IN GLUTAMATE-CYSTEINE LIGASE DEFICIENCY AND Β-THALASSEMIA TRAIT COINHERITANCE
EHA Library, Carina Levin, 420288
FATIGUE SEVERITY THRESHOLDS IN COLD AGGLUTININ DISEASE: POST-HOC ANALYSES ON THE FACIT-FATIGUE SCALE FROM TWO PHASE 3 TRIALS
EHA Library, David Cella, 420289
RETICULOCYTE HEMOGLOBIN EQUIVALENT IN THE DIAGNOSIS OF IRON DEFICIENCY
EHA Library, Ikbel Ghachem, 420290
RETICULOCYTE HEMOGLOBIN CONTENT IN COMPARISON WITH BIOCHEMICAL MARKERS FOR IDENTIFYING IRON DEFICIENCY IN LYMPHOMA PATIENTS WITH ANEMIA
EHA Library, Nina Petkova, 420291
SHOULD TRANSFERRIN SATURATION >45% OR HIGH SERUM TRANSFERRIN LEVEL BE THE ONLY REQUIREMENT FOR HH GENE MUTATION DETECTION?
EHA Library, Hatice Demet Kiper Unal, 420292
SIRES (SEARCHING FOR IRON-RESPONSIVE ELEMENTS) SERVER 3.0: IMPROVED BIOINFORMATIC PREDICTIONS FOR IRON-RESPONSIVE ELEMENTS (IRES) RNA MOTIFS
EHA Library, Clara Suarez-Quintana, 420293
THE CONNECTION OF INTESTINAL MICROBIOTA IN THE DEVELOPMENT OF IRON DEFICIENCY ANEMIA IN PATIENTS OF REPRODUCTIVE AGE
EHA Library, Anna Bakirova, 420294
EFFICACY OF LETERMOVIR AS PRIMARY PROPHYLAXIS OF CMV REACTIVATION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT: SINGLE-CENTER ANALYSIS
EHA Library, Nevena Bešević, 420295
SARS-COV-2 IN PATIENTS WITH ONCOHEMATOLOGIC DISEASES AND HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCT) IN 2023: A MAJOR SHIFT TO MILDER FORMS OF COVID-19
EHA Library, Blanca Vegas, 420296
THE RELATIONSHIP BETWEEN IMMUNOLOGICAL RECONSTITUTION AFTER AHSCT AND THE OCCURRENCE OF EARLY INFECTIONS IN PATIENTS WITH LYMPHOPROLIFERATIVE NEOPLASMS
EHA Library, Agnieszka Szymczyk, 420297
THE COLOGNE ECMM EXCELLENCE CENTER: A COMPREHENSIVE EVALUATION OF ITS EXTERNAL CONSULTATION SERVICE FOR INVASIVE FUNGAL INFECTIONS OVER TWO YEARS
EHA Library, Jon Salmanton-García, 420298
IMMUNOGENICITY OF COVID-19 BOOSTER (COMINARTY-OMICRON XBB 1.5®) IN LONG-TERM SURVIVORS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Sigrun Einarsdottir, 420299
ASSESSMENT OF THE T-CELL-MEDIATED SARS-COV-2-SPECIFIC IMMUNE RESPONSE IN PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION – A PROSPECTIVE DIAGNOSTIC STUDY
EHA Library, Michaela Steinhilper, 420300
CENTRAL VENOUS CATHETER AND BACTERIAL INFECTIONS AT PATIENTS WITH ACUTE LEUKEMIA-  OUTCOME SINGLE CENTER EXPIRIANCE
EHA Library, Violeta Milosevic, 420301
BACTERIAL INFECTIONS BEFORE AND AFTER ALLOGENEIC STEM CELL TRANSPLANTATION AND ITS IMPACT ON SURVIVAL
EHA Library, Natalija Kecman, 420302
SERBIAN REAL-WORLD DATA OF MARIBAVIR IN STEM CELL TRANSPLANT RECIPIENTS
EHA Library, Milena Todorovic Balint, 420303
THE EFFECTIVENESS OF LEVOFLOXACIN IN PREVENTION OF FEBRILE EPISODES IN NON-HODGKIN LYMPHOMA PATIENTS RECEIVING RITUXIMAB, CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN AND PREDNISOLONE (R-CHOP)
EHA Library, Mutita Surakijboworn, 420304
PHASE II TRIAL OF POSACONAZOLE PROPHYLAXIS DURING ANTI-THYMOCYTE GLOBULIN TREATMENT FOR APLASTIC ANEMIA AND HYPOPLASTIC MYELODYSPLASTIC SYNDROME
EHA Library, Dong Hyun Kim, 420305
THE INCIDENCE OF INFECTIONS AND ITS EFFECTS ON MORTALITY IN AML PATIENTS TREATED WITH VENETOCLAX
EHA Library, Tugcan Alp Kirkizlar, 420306
FREQUENCY OF FUNGAL INFECTIONS IN NEWLY DIAGNOSED AML PATIENTS TREATED WITH VENETOCLAX PLUS AZACITIDINE WITH OR WITHOUT ANTIFUNGAL PROPHYLAXIS
EHA Library, Barbora Weinbergerová, 420307
FERROPTOSIS AND DYSFUNCTION OF CD3+CD4−CD8−T CELLS ARE ASSOCIATED WITH POOR IMMUNE RECONSTITUTION IN PEOPLE LIVING WITH HIV
EHA Library, Xi Quan, 420308
POST-ARTESUNATE DELAYED HEMOLYSIS IN CHILDREN WITH SEVERE MALARIA: INCIDENCE, RISK FACTORS AND MEDICAL IMPACT
EHA Library, Valentine Carret, 420309
BONE MARROW EXAMINATION IN THE DIAGNOSIS OF INFECTIOUS PATHOLOGY: AN OFTEN UNDERUTILIZED DIAGNOSTIC TOOL.
EHA Library, Priyavadhana Balasubramanian, 420310
SAFETY OF ANTIVIRAL THERAPY DISCONTINUATION FOLLOWING RECOMBINANT VARICELLA ZOSTER VIRUS VACCINATION IN PATIENTS WITH HEMATOLOGICAL CONDITIONS
EHA Library, Carlos Aguilar, 420311
EXPERIENCE WITH CENTRAL VEIN CATHETERIZATION IN PATIENTS WITH HEMATHOLOGICAL DISORDERS. COMPLICATIONS ASSOCIATED WITH THE TECHNIQUE OF INSERTION
EHA Library, Nikolay Romanenko, 420312
PREHOSPITAL TRANSFUSION OF RED-CELL CONCENTRATES IN THE HEMS (HELICOPTER EMERGENCY MEDICAL SERVICES) OF THE 112-SOS ARAGÓN. RESULTS AFTER 4 YEARS OF EXPERIENCE.
EHA Library, José María Domingo-Morera, 420313
CHARACTERISTICS OF CHANGES IN PLATELET CONCENTRATE UNDER CONDITIONS OF COMBINED HYPOTHERMIC STORAGE
EHA Library, Daria Lastochkina, 420314
CONTAMINATION OF UNCERTAIN ORIGIN ACQUIRED AFTER PLATELET APHERESIS INACTIVATION: A CASE REPORT AND LITERATURE REVIEW
EHA Library, Mónica Fernández Pérez, 420315
PLATELET CONTENT IN RBC UNITS AND FACTORS INFLUENCING IT
EHA Library, Asma Boughanmi, 420316
THE INFLUENCE OF INFLAMMATORY CYTOKINES AND HEPSIDIN ON THE DEVELOPMENT OF ANEMIA AND THE EFFECTIVENESS OF ANEMIA CORRECTION WITHOUT RED BLOOD TRANSFUSIONS IN GASTRIC CANCER AFTER NEOADJUVANT THERAPY
EHA Library, Nikolay Romanenko, 420317
ITALIAN REAL-WORLD EXPERIENCE WITH FOSTAMATINIB IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA
EHA Library, Francesco Zaja, 420319
CAPLACIZUMAB TREATMENT IN ELDERLY PATIENTS WITH ITTP: UPDATED EXPERIENCE FROM THE SPANISH TTP REGISTRY
EHA Library, Inés Gómez Seguí, 420320
REAL-WORLD INSIGHTS INTO AVATROMBOPAG’S EFFECTIVENESS AND SAFETY IN ADULTS WITH IMMUNE THROMBOCYTOPENIA
EHA Library, Barbara Skopec, 420321
PHASE 4 ADOPT STUDY: INTERIM ANALYSIS OF EFFICACY AND SAFETY RESULTS OF AVATROMBOPAG TREATMENT IN ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIA
EHA Library, María Eva Mingot Castellano, 420322
CLINICAL PREDICTORS OF RESPONSE TO THE ORAL BRUTON TYROSINE KINASE INHIBITOR RILZABRUTINIB IN PREVIOUSLY TREATED PATIENTS WITH IMMUNE THROMBOCYTOPENIA: POOLED ANALYSIS OF PHASE 2 STUDY
EHA Library, Waleed Ghanima, 420323
DAPSONE IS AN EFFECTIVE AGENT FOR REFRACTORY ITP: ANALYSIS OF UK ADULT ITP REGISTRY
EHA Library, Giacinto Luca Pedone, 420324
BLEEDING COMPLICATIONS AND PLATELET DYSFUNCTION IN PATIENTS WITH NON-TERMINAL CHROMOSOMAL 11Q-DELETIONS OR 11Q-DUPLICATIONS
EHA Library, Elise Huisman, 420325
USE OF CORTICOSTEROID-SPARING TREATMENTS (2ND-LINE AND BEYOND) IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA IN EUROPE. A PARALLEL STUDY IN SIX PROSPECTIVE MULTICENTER NATIONAL REGISTRIES
EHA Library, Guillaume Moulis, 420326
AVATROMBOPAG IN IMMUNE THROMBOCYTOPENIA (PTI).  A REAL-WORLD STUDY OF THE SPANISH ITP GROUP (GEPTI).
EHA Library, CRISTINA PASCUAL IZQUIERDO, 420327
LONG-TERM RESULTS OF THROMBOPOIETIN RECEPTOR AGONIST WITHDRAWAL IN PRIMARY IMMUNE THROMBOCYTOPENIA RESISTANT TO STANDARD TREATMENT
EHA Library, Olga Vinogradova, 420328
MANAGEMENT OF GLANZMANN THROMBASTHENIA: A EUROPEAN SURVEY ON CURRENT CLINICAL PRACTICE
EHA Library, Roger SCHUTGENS, 420329
MATERNAL AND NEONATAL OUTCOMES IN A COHORT OF EGYPTIAN WOMEN WITH NON-GESTATIONAL THROMBOCYTOPENIA
EHA Library, Mona Mahrous Abdelaty, 420330
THE DIFFERENCE IN N-GLYCOSYLATION OF IMMUNOGLOBULIN G BETWEEN ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIA AND HEALTHY CONTROLS
EHA Library, Ena Ranković, 420331
REAL-WORLD USE OF FOSTAMATINIB IN FRANCE. RESULTS OF A NATIONAL REGISTRY AT TWO YEARS AFTER MARKETING.
EHA Library, Guillaume Moulis, 420332
RISK OF CANCER IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: A FRENCH NATIONWIDE POPULATION-BASED STUDY
EHA Library, Yoann Zadro, 420333
CLINICAL UTILITY OF TARGETED NEXT‐GENERATION SEQUENCING PANEL FOR GENETIC DIAGNOSIS OF PATIENTS WITH SUSPECTED INHERITED THROMBOCYTOPENIA
EHA Library, Marta Moreno Carbonell, 420334
REAL-WORLD EFFECTIVENESS AND SAFETY OF ROMIPLOSTIM IN FRANCE. RESULTS FROM THE PROSPECTIVE, MULTICENTER, NATIONAL CARMEN-FRANCE REGISTRY.
EHA Library, Guillaume Moulis, 420335
SAFETY, PHARMACOKINETICS, AND EFFICACY OF ELIGLUSTAT ADMINISTERED WITH AND WITHOUT IMIGLUCERASE IN PAEDIATRIC PARTICIPANTS WITH GAUCHER DISEASE TYPE 1 OR 3: THE ELIKIDS STUDY
EHA Library, Pilar Giraldo, 420336
REAL-WORLD EFFECTIVENESS OF HETROMBOPAG FOR CANCER THERAPY-INDUCED THROMBOCYTOPENIA IN CANCER PATIENTS
EHA Library, Ning Li, 420338
MUTATION SPECTRUM OF F5 GENE IN PATIENTS WITH FV DEFICIENCY FROM RUSSIA
EHA Library, Olesya Pshenichnikova, 420339
THE APPLICATION OF MINIGENE TRANSCRIPTION ANALYSIS IN THE DIAGNOSIS AND TREATMENT OF INFANTILE MYOFIBROMATOSIS (IM) WITH HEMOPHILIA A
EHA Library, Yufeng Wei, 420340
THROMBOELASTOGRAM AND ITS USE IN CARDIAC SURGERY, A SERVICE EVALUATION
EHA Library, Silvia Lovato, 420341
EVALUATION OF HEREDITARY FRUCTOSE TOLERANCE IN PREVALENT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA, HEMOLYTIC UREMIC SYNDROME, OR MYASTHENIA GRAVIS
EHA Library, Sandra Lewis, 420342
THE EVOLVING LANDSCAPE OF HEMOPHILIA A TREATMENTS: GAINS VS. UNMET NEEDS
EHA Library, Aine Kyle, 420343
ENHANCED IMMUNOTHERAPY YIELDS SUPERIOR EFFICACY IN PATIENTS WITH HIGH-TITER ACQUIRED HEMOPHILIA A
EHA Library, Li Zhou, 420344
SURGICAL INTERVENTIONS AND BLEEDING MANAGEMENT IN  INHERITED FACTOR VII DEFICIENCY
EHA Library, Betül Kübra Tüzün, 420345
BLEEDING DISORDERS IN PREGNANCY: A SINGLE INSTITUTION EXPERIENCE
EHA Library, Katie Liston, 420346
REGIONAL DIFFERENCES IN HEMOPHILIA A TREATMENT APPROACHES: A COMPARISON OF PROPHYLAXIS TREATMENT USAGE BETWEEN THE US AND EUROPE
EHA Library, Aine Kyle, 420347
CURRENT PRACTICE REGARDING BLEEDING DISORDER OF UNKNOWN CAUSE (BDUC) IN THE NETHERLANDS: A NATIONAL SURVEY
EHA Library, Floor Heubel-Moenen, 420348
GENEALOGICAL INSIGHT: UNCOVERING TYPE 2N VON WILLEBRAND DISEASE AND CARRIERS WITH HOMOZYGOUS R816W MUTATION IN THE VWF GENE
EHA Library, Monica Fernandes Pineda, 420349
THE GLANZMANN’S THROMBASTHENIA: A TUNISIAN PEDIGREE FROM SFAX IN THE SOUTH OF TUNISIA
EHA Library, Nouha Bouayed Abdelmoula, 420350
RARE DEFICITS IN COAGULATION FACTORS
EHA Library, Hajar TOURBIH, 420351
THE QUALITY OF LIFE OF ADULT PATIENTS WITH HEMOPHILIA IN NOVOSIBIRSK AND NOVOSIBIRSK REGION
EHA Library, Tatiana Babaeva, 420352
DIAGNOSING AND TREATING BLEEDING DISORDER OF UNKNOWN CAUSE: AN ILLUSTRATED REVIEW ON CURRENT PRACTICE AND FUTURE DIRECTIONS
EHA Library, Floor Heubel-Moenen, 420353
COMORBIDITY OF HEMOPHILIA PATIENTS IN THE NOVOSIBIRSK REGION
EHA Library, Tatiana Babaeva, 420354
GENETIC COUNSELLING IN HEMOPHILIA C: ABOUT A TUNISIAN PEDIGREE FROM SFAX
EHA Library, Nouha Bouayed Abdelmoula, 420355
DIAGNOSIS OF VON WILLEBRAND DISEASE (VWD) TYPE 2A IN MIDDLE AGE OF LIFE IN A PATIENT WITH NO HISTORY OF BLEEDING COMPLICATIONS DUE TO PREVIOUS HEMOSTATIC CHALLENGES.
EHA Library, Carmen Loredo Alvarez, 420356
ADMINISTRATION OF ACETYLSALICYLIC ACID IN SEVERE TYPE HEMOPHILIA A PATIENT ON  EMICIZUMAB PROPHYLAXIS WITH CEREBROVASCULAR INSULT - CASE REPORT
EHA Library, Branimir Micanovic, 420357

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings